false 0001140215 0001140215 2023-11-09 2023-11-09 0001140215 dei:FormerAddressMember 2023-11-09 2023-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 9, 2023

 

REED’S, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-32501   35-2177773

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

201 Merritt 7 Corporate Park, Norwalk, CT 06851

(Address of principal executive offices and zip code)

 

Not applicable

(Former name or former address if changed since last report)

 

Registrant’s telephone number, including area code: (310) 217-9400

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchanged on Which Registered
         

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On November 9, 2023, Reed’s, Inc., a Delaware corporation (the “company” or “Reed’s”) issued a press release announcing financial results for the third quarter ended September 30, 2023. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Reed’s will conduct a conference call tomorrow, November 10, 2023, at 8:30 a.m. Eastern time to discuss its results for the three months ended September 30, 2023.

 

Reed’s management will host the conference call, followed by a question-and-answer period.

 

Date: Friday, November 10, 2023

Time: 8:30 a.m. Eastern time

Toll-free dial-in number: (844) 850-0544

International dial-in number: (412) 542-4115

Conference ID: 10184105

Webcast: Reed’s Q3 2023 Conference Call

 

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at (720) 330-2829.

 

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://investor.reedsinc.com.

 

Item 7.01. Regulation FD Disclosure.

 

See “Item 2.02 Results of Operations and Financial Condition” above.

 

The information in this Current Report on Form 8-K under Items 2.02 and 7.01, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by a specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The following exhibit is furnished with this Current Report on Form 8-K:

 

Exhibit No.   Description
99.1   Press Release of Reed’s Inc. dated November 9, 2023

 

   

 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  REEDS, INC.,
  a Delaware corporation
     
Dated: November 9, 2023 By: /s/ Norman E. Snyder, Jr.
    Norman E. Snyder, Jr.
    Chief Executive Officer

 

   

 

 

 

 

Exhibit 99.1

 

 

Reed’s Reports Third Quarter 2023 Results

 

Gross Margin Expansion and Continued Operating Expense Reductions Lead to First Quarter of Modified EBITDA Profitability Since 2016

and Operating Loss improvement to $0.1 million

 

Norwalk, CT, (November 9, 2023) – Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three months ended September 30, 2023.

 

Q3 2023 Financial Highlights (vs. Q3 2022):

 

  Net sales were $11.9 million compared to $12.1 million.
  Gross profit increased 66% to $4.0 million compared to $2.4 million, with gross margin up 1,390 basis points to 34.0% compared to 20.1%.
  Delivery and handling costs were reduced by 15% to $2.98 per case.
  Selling, general and administrative expenses were reduced by 14% to $2.3 million.
  Operating loss improved to $0.1 million compared to $2.5 million.
  Modified EBITDA improved to $0.2 million compared to $(2.2) million

 

Management Commentary

 

“I am pleased with the progress we made in the third quarter as we continued to lower input costs and freight expenses, enabling us to materially expand gross margin and reach our guidance of turning modified EBITDA profitable,” said Norman E. Snyder, CEO of Reed’s. “We also achieved our guidance of realizing $6 million in annual operating expense reductions, which reflects our prudent cost management across multiple areas of the business. Although we considerably improved profitability, net sales were impacted by a delay in our seasonal programs which will be recognized in the fourth quarter, as well as short order shipments. We have made progress on reducing short shipments by building up our inventory levels and expect to capitalize on strong seasonal demand in the months ahead.

 

“Given the inventory challenges, we are revising our net sales guidance for 2023 to range between $45 and $47 million, however we expect to maintain our modified EBITDA profitability and exceed our guidance of realizing $6 million of operating expense reductions for the year. With ongoing efforts to bolster inventory levels, an optimized cost structure, and continued strong demand for Reed’s products, we are well positioned to deliver on our near-term objectives.”

 

   

 

 

Third Quarter 2023 Financial Results

 

During the third quarter of 2023, net sales were $11.9 million compared to $12.1 million in the year-ago period. The decrease was primarily driven by delayed seasonal shipments and, to a lesser extent, short order shipments. Reed’s expects to recognize the delayed seasonal shipments in the fourth quarter of 2023.

 

Gross profit for the third quarter of 2023 increased 66% to $4.0 million compared to $2.4 million in the same period of 2022. Gross margin increased 1,390 basis points to 34.0% compared to 20.1% in the year-ago quarter. The increase was primarily driven by lower supply chain and input costs.

 

Delivery and handling costs were reduced by 15% to $1.9 million during the third quarter of 2023 compared to $2.2 million in the third quarter of 2022. The decrease was primarily driven by renegotiated freight contracts, improved throughput, as well as the Company’s streamlined distribution orbit model. Delivery and handling costs were reduced to 16% of net sales or $2.98 per case, compared to 19% of net sales or $3.38 per case during the same period last year.

 

Selling, general and administrative costs declined by 14% to $2.3 million during the third quarter of 2023 compared to $2.6 million in the year-ago quarter. As a percentage of net sales, selling, general and administrative costs were reduced to 19% compared to 22%.

 

Operating loss during the third quarter of 2023 improved to $0.1 million or $(0.03) per share, compared to $2.5 million or $(1.09) per share in the third quarter of 2022.

 

Modified EBITDA improved to $0.2 million in the third quarter of 2023 compared to $(2.2) million in the third quarter of 2022.

 

Liquidity and Cash Flow

 

For the third quarter of 2023, cash used in operations was $1.8 million compared to $0.2 million for the same period in 2022. The increase in cash used was primarily driven by higher inventory purchases compared to the year-ago period.

 

As of September 30, 2023, the Company had approximately $1.0 million of cash and $26.8 million of total debt net of capitalized financing fees. The debt includes $17.1 million from a convertible note and $9.7 million from the Company’s revolving line of credit, which has $3.1 million of additional borrowing capacity.

 

   

 

 

FY 2023 Financial Outlook

 

Based on the inventory shortage faced year-to-date, the Company is revising its net sales guidance to range between $45 million and $47 million for 2023 and now expects to turn cash flow positive in 2024 as the Company utilizes its cash to increase inventory in the fourth quarter. However, the Company expects to maintain its modified EBITDA profitability and exceed its guidance of realizing $6 million of operating expense reductions for the year.

 

Conference Call

 

The Company will conduct a conference call tomorrow, November 10, 2023, at 8:30 a.m. Eastern time to discuss its results for the three months ended September 30, 2023.

 

Reed’s management will host the conference call, followed by a question-and-answer period.

 

Date: Friday, November 10, 2023

Time: 8:30 a.m. Eastern time

Toll-free dial-in number: (844) 850-0544

International dial-in number: (412) 542-4115

Conference ID: 10184105

Webcast: Reed’s Q3 2023 Conference Call

 

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at (720) 330-2829.

 

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://investor.reedsinc.com.

 

About Reed’s, Inc.

 

Reed’s is an innovative company and category leader that provides the world with high quality, premium and naturally bold™ better-for-you beverages. Established in 1989, Reed’s is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 45,000 stores nationwide.

 

Reed’s is known as America’s #1 name in natural, ginger-based beverages. Crafted using real ginger and premium ingredients, Reed’s portfolio includes ginger beers, ginger ales, ready-to-drink ginger mules and hard ginger ales. The brand has recently successfully expanded into the zero-sugar segment with its proprietary, natural sweetener system.

 

   

 

 

Virgil’s® is an award-winning line of craft sodas, made with the finest natural ingredients and without GMOs or artificial preservatives. The brand offers an array of great tasting, bold flavored sodas including Root Beer, Vanilla Cream, Black Cherry, Orange Cream, and more. These flavors are also available in nine zero sugar varieties which are naturally sweetened and certified ketogenic.

 

Flying Cauldron® is a non-alcoholic butterscotch beer prized for its creamy vanilla and butterscotch flavors. Sought after by beverage aficionados, Flying Cauldron is made with natural ingredients and no artificial flavors, sweeteners, preservatives, gluten, caffeine, or GMOs.

 

For more information, visit drinkreeds.com, virgils.com and flyingcauldron.com. To receive exclusive perks for Reed’s investors, please visit the Company’s page on the Stockperks app here.

 

Forward-Looking Statements

 

Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are typically identified by terms such as “estimate,” “expect,” “intend,” “project,” “will,” “plan,” and similar expressions. These forward-looking statements are based on current expectations and include our management’s expectations and guidance for fiscal year 2023 under the heading “FY 2023 Financial Outlook”. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties, and assumptions, many of which involve factors or circumstances that are beyond our control. Reed’s 2023 guidance reflects year-to-date and expected future business trends and includes impacts of the inventory shortage as of the date hereof. New supply chain challenges that may develop and further potential inflation cannot be reasonably estimated and are not factored into current fiscal 2023 guidance. These risks could materially impact our ability to access raw materials, production, transportation and/or other logistics needs.

 

Financial guidance should not be viewed as a substitute for full financial statements prepared in accordance with GAAP.

 

If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, Reed’s actual results could differ materially from the results expressed or implied by the forward-looking statements we make, including our ability to achieve our targets for the fiscal year ending December 31, 2023. The risks and uncertainties referred to above include, but are not limited to: inventory shortages; risks associated with new product releases; the impacts of further inflation; risks that customer demand may fluctuate or decrease; risks that we are unable to collect unbilled contractual commitments, particularly in the current economic environment; our ability to compete successfully and manage growth; our significant debt obligations; our ability to develop and expand strategic and third party distribution channels; our dependence on third party suppliers, brewers and distributors; third party co-packers meeting contractual commitments; risks related to our international operations; our ability to continue to innovate; our strategy of making investments in sales to drive growth; increasing costs of fuel and freight, protection of intellectual property; competition; general political or destabilizing events, including the wars in Ukraine and Israel, conflict or acts of terrorism; financial markets, commodity and currency impacts of the wars; the effect of evolving domestic and foreign government regulations, including those addressing data privacy and cross-border data transfers; and other risks detailed from time to time in Reed’s public filings, including Reed’s annual report on Form 10-K filed on May 15, 2023 and its Quarterly Report on Form 10Q, expected to be filed on November 10, 2023, which are (or will be) available on the Securities and Exchange Commission’s web site at www.sec.gov. These forward-looking statements are based on current expectations and speak only as of the date hereof. Reed’s assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

Investor Relations Contact

Sean Mansouri, CFA

Elevate IR

ir@reedsinc.com

(720) 330-2829

 

   

 

 

REED’S, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the Three and Nine Months Ended September 30, 2023 and 2022

(Unaudited)

(Amounts in thousands, except share and per share amounts)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Sales  $11,856   $12,094   $33,018   $38,001 
Cost of goods sold   7,823    9,659    23,778    29,335 
Gross profit   4,033    2,435    9,240    8,666 
                     
Operating expenses:                    
Delivery and handling expense   1,908    2,249    5,714    8,893 
Selling and marketing expense   861    1,220    3,567    5,623 
General and administrative expense   1,407    1,420    4,427    5,319 
Total operating expenses   4,176    4,889    13,708    19,835 
                     
Loss from operations   (143)   (2,454)   (4,468)   (11,169)
                     
Interest expense   (1,293)   (777)   (4,459)   (2,119)
                     
Net loss   (1,436)   (3,231)   (8,927)   (13,288)
                     
Dividends on Series A Convertible Preferred Stock   -    -    (5)   (5)
                     
Net Loss Attributable to Common Stockholders  $(1,436)  $(3,231)  $(8,932)  $(13,293)
                     
Loss per share – basic and diluted  $(0.34)  $(1.43)  $(2.69)  $(6.54)
                     
Weighted average number of shares outstanding – basic and diluted   4,169,131    2,254,356    3,322,959    2,030,503 

 

   

 

 

REED’S, INC,

CONDENSED BALANCE SHEETS

(Amounts in thousands, except share amounts)

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS          
Current assets:          
Cash  $1,004   $533 
Accounts receivable, net of allowance of $514 and $252, respectively   5,267    5,671 
Inventory, net   15,964    16,175 
Receivable from former related party   777    777 
Prepaid expenses and other current assets   489    939 
Total current assets   23,501    24,095 
           
Property and equipment, net of accumulated depreciation of $1,001 and $787, respectively   559    766 
Intangible assets   627    626 
Total assets  $24,687   $25,487 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $9,067   $9,805 
Accrued expenses   873    233 
Revolving line of credit, net of capitalized financing costs of $242 and $363, respectively   9,697    10,974 
Convertible notes payable, current portion, net of debt discount of $0 and $414, respectively   7,380    2,434 
Payable to former related party   452    2,025 
Current portion of lease liabilities   209    187 
Total current liabilities   27,678    25,658 
           
Convertible note payable, net of debt discount of $252 and $562, respectively, less current portion   9,721    8,092 
Lease liabilities, less current portion   48    207 
Total liabilities   37,447    33,957 
           
Stockholders’ deficit:          
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding   94    94 
Common stock, $.0001 par value, 180,000,000 shares authorized; 4,169,131 and 2,519,485 shares issued and outstanding, respectively   -    - 
Additional paid in capital   119,277    114,635 
Accumulated deficit   (132,131)   (123,199)
Total stockholders’ deficit   (12,760)   (8,470)
Total liabilities and stockholders’ deficit  $24,687   $25,487 

 

 
 

 

 

REED’S, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30, 2023 and 2022

(Unaudited)

(Amounts in thousands)

 

   September 30,   September 30, 
   2023   2022 
Cash flows from operating activities:          
Net loss  $(8,927)  $(13,288)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   112    79 
Loss on disposal of property and equipment   9    - 
Amortization of debt discount   958    307 
Amortization of prepaid financing costs   -    431 
Fair value of vested options   351    448 
Fair value of vested restricted shares granted to officers   3    137 
Fair value of common shares issued as financing costs   -    37 
Change in allowance for doubtful accounts   262    (152)
Inventory write-downs   (205)   35 
Accrued interest   2,483    386 
Changes in operating assets and liabilities:          
Accounts receivable   142    (673)
Inventory   417    (2,901)
Prepaid expenses and other assets   450    (399)
Decrease in right of use assets   102    86 
Accounts payable   (738)   (860)
Accrued expenses   639    (62)
Accrued dividend   (5)   - 
Lease liabilities   (137)   (118)
Net cash used in operating activities   (4,084)   (16,507)
           
Cash flows from investing activities:          
Trademark costs   (1)   (2)
Purchase of property and equipment   (84)     
Proceeds from sale of property and equipment   68    - 
Net cash used in investing activities   (17)   (2)
           
Cash flows from financing activities:          
Proceeds from line of credit   32,686    40,576 
Payments on line of credit   (34,085)   (41,299)
Payments of debt issuance costs   -    (483)
Proceeds from sale of common stock   4,016    5,034 
Proceeds from convertible note payable, net of expenses   3,797    12,430 
Payment of convertible note payable   (268)   (400)
Repurchase of common stock   (1)   (2)
Amounts from former related party, net   (1,573)   629 
Net cash provided by financing activities   4,572    16,485 
           
Net increase (decrease) in cash   471    (24)
Cash at beginning of period   533    49 
Cash at end of period  $1,004   $25 
           
Supplemental disclosures of cash flow information:          
Cash paid for interest  $548   $1,051 
           
Non -cash investing and financing activities          
Dividends on Series A Convertible Preferred Stock  $5   $5 

 

   

 

 

Modified EBITDA

 

In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus, interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

 

Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

 

Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended September 30, 2023, and 2022 (unaudited; in thousands):

 

   Three Months Ended 
    September 30 
   2023   2022 
Net loss  $(1,436)  $(3,231)
           
Modified EBITDA adjustments:          
Depreciation and amortization   68    58 
Interest expense   1,293    777 
Stock option and other noncash compensation   139    214 
Severance   85    - 
Legal settlements   12    - 
Total EBITDA adjustments  $1,597   $1,049 
           
Modified EBITDA  $161   $(2,182)

 

We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

 

  Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
  Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
  Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
  Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

 

   

 

v3.23.3
Cover
Nov. 09, 2023
Entity Addresses [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 09, 2023
Entity File Number 001-32501
Entity Registrant Name REED’S, INC.
Entity Central Index Key 0001140215
Entity Tax Identification Number 35-2177773
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 201 Merritt 7 Corporate Park
Entity Address, City or Town Norwalk
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06851
City Area Code (310)
Local Phone Number 217-9400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Former Address [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 201 Merritt 7 Corporate Park
Entity Address, City or Town Norwalk
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06851

Reeds (QX) (USOTC:REED)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Reeds (QX) 차트를 더 보려면 여기를 클릭.
Reeds (QX) (USOTC:REED)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Reeds (QX) 차트를 더 보려면 여기를 클릭.